학술논문
Impact on direct and indirect costs of switching patients with inflammatory bowel disease from intravenous to subcutaneous infliximab (CT-P13)
Document Type
Article
Author
Source
In: BMJ Open Gastroenterology . (BMJ Open Gastroenterology, 22 February 2023, 10(1))
Subject
Language
English
ISSN
20544774